Fig. 3From: Long-term drug costs per life-month gained associated with first-line treatments for unresectable or metastatic melanomaProjected overall survival for up to 7 years following first-line BRAF inhibitors based on Weibull model. The solid line indicates observed overall survival and the line of circles indicates projected overall survival based on parametric survival modelingBack to article page